학술논문

Hyperactivation of TORC1 Drives Resistance to the Pan-HER Tyrosine Kinase Inhibitor Neratinib in HER2-Mutant Cancers
Document Type
Article
Source
In: Cancer Cell. (Cancer Cell, 10 February 2020, 37(2):183-199.e5)
Subject
Language
English
ISSN
18783686
15356108